Medicare Enrolled
Dr. Ronjay Rakkhit, M.D.
Internal Medicine · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rakkhit from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rakkhit?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rakkhit
Dr. Ronjay Rakkhit is an internal medicine specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rakkhit performed 178,592 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rakkhit received a total of $13,481 from 75 pharmaceutical and/or device companies across 586 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rakkhit is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in TX
$13,481 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗178,592
Medicare services
Top 0% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
77,520 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
47,200 | $2 | $13 |
| Pembrolizumab injection (Keytruda) | 24,600 | $43 | $223 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
10,600 | $0 | $0 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,500 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,090 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,800 | $6 | $33 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,510 | $1 | $4 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,192 | $8 | $24 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
820 | $65 | $278 |
| Pegfilgrastim-jmdb injection An injection of pegfilgrastim-jmdb, a biosimilar medication. The dose specified is 0.5 mg. |
516 | $97 | $553 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
304 | $8 | $10 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
297 | $22 | $91 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
291 | $11 | $53 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
286 | $102 | $417 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
273 | $2 | $11 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
180 | $12 | $49 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
175 | $49 | $203 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
112 | $16 | $71 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 112 | $101 | $492 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
111 | $1,186 | $5,521 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
108 | $51 | $205 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
106 | $20 | $89 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
99 | $80 | $344 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
89 | $44 | $175 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
82 | $5 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
78 | $100 | $408 |
| CT scan of chest with and without contrast A computed tomography scan of the chest performed using both intravenous contrast dye and without it to provide detailed images of internal structures. |
71 | $58 | $638 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
69 | $212 | $1,119 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
48 | $20 | $81 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
39 | $115 | $496 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
39 | $1 | $5 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
37 | $3 | $11 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
35 | $16 | $63 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
29 | $176 | $1,019 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
29 | $13 | $43 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
28 | $51 | $570 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
21 | $26 | $104 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $34 | $177 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
16 | $59 | $430 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
16 | $108 | $621 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
16 | $1 | $5 |
| New patient office visit, complex (60-74 min) | 15 | $178 | $681 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $139 | $567 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
43.9% high complexity
54.4% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,481
Total received (2018-2024)
Avg $1,926/year across 7 years
Top 7% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
586
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,555
2023
$1,912
2022
$3,597
2021
$872
2020
$1,131
2019
$2,271
2018
$2,144
Payments by company (2024)
PFIZER INC.
$170
Celgene Corporation
$154
Tempus AI, Inc
$154
Merck Sharp & Dohme LLC
$142
SpringWorks Therapeutics, Inc.
$135
E.R. Squibb & Sons, L.L.C.
$133
GENZYME CORPORATION
$113
Novartis Pharmaceuticals Corporation
$78
Gilead Sciences, Inc.
$65
JAZZ PHARMACEUTICALS INC.
$62
AstraZeneca Pharmaceuticals LP
$52
Eisai Inc.
$45
Exelixis Inc.
$44
Janssen Biotech, Inc.
$42
PharmaEssentia USA Corporation
$40
Fennec Pharmaceuticals, Inc.
$31
Astellas Pharma US Inc
$30
Takeda Pharmaceuticals U.S.A., Inc.
$25
BeiGene USA, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$17
Top 3 companies account for 30.7% of 2024 payments
All-time payments by company (2018-2024) ›
SERVIER PHARMACEUTICALS LLC
$2,240
PFIZER INC.
$1,214
Novartis Pharmaceuticals Corporation
$1,181
Janssen Biotech, Inc.
$1,000
E.R. Squibb & Sons, L.L.C.
$859
Amgen Inc.
$805
Celgene Corporation
$583
GENZYME CORPORATION
$429
Genentech USA, Inc.
$411
Janssen Pharmaceuticals, Inc
$335
Gilead Sciences, Inc.
$297
Merck Sharp & Dohme LLC
$267
Astellas Pharma US Inc
$219
Exelixis Inc.
$176
AstraZeneca Pharmaceuticals LP
$161
ARRAY BIOPHARMA INC
$160
Takeda Pharmaceuticals U.S.A., Inc.
$154
Tempus AI, Inc
$154
Medtronic, Inc.
$152
SpringWorks Therapeutics, Inc.
$135
Myriad Genetic Laboratories, Inc.
$124
BeiGene USA, Inc.
$120
GlaxoSmithKline, LLC.
$116
Sirtex Medical Inc
$108
Merck Sharp & Dohme Corporation
$102
Alexion Pharmaceuticals, Inc.
$99
Lilly USA, LLC
$95
Eisai Inc.
$89
Lexicon Pharmaceuticals, Inc.
$86
JAZZ PHARMACEUTICALS INC.
$82
Verity Pharmaceuticals Inc.
$79
Secura Bio, Inc.
$73
Pharmacyclics LLC, An AbbVie Company
$72
Kite Pharma, Inc.
$62
Clovis Oncology, Inc.
$62
Foundation Medicine, Inc.
$61
Boston Scientific Corporation
$59
Jazz Pharmaceuticals Inc.
$58
Puma Biotechnology, Inc.
$56
Incyte Corporation
$54
Bayer HealthCare Pharmaceuticals Inc.
$51
Taiho Oncology, Inc.
$51
Regeneron Healthcare Solutions, Inc.
$45
MorphoSys, US Inc.
$41
PharmaEssentia USA Corporation
$40
Biocompatibles, Inc.
$39
PUMA BIOTECHNOLOGY, INC.
$38
Sobi, Inc
$33
EISAI INC.
$32
Teva Pharmaceuticals USA, Inc.
$32
Fennec Pharmaceuticals, Inc.
$31
TESARO, Inc.
$30
SECURA BIO, INC.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Adaptive Biotechnologies Corporation
$24
Apellis Pharmaceuticals, Inc.
$23
AVEO Pharmaceuticals, Inc.
$22
ABBVIE INC.
$22
AbbVie, Inc.
$22
EUSA Pharma (US) LLC
$20
Janssen Scientific Affairs, LLC
$20
Servier Pharmaceuticals LLC
$20
Ipsen Biopharmaceuticals, Inc
$19
Sysmex Inostics Inc
$18
R-Pharm US LLC
$18
Dendreon Pharmaceuticals LLC
$18
EMD Serono, Inc.
$17
INSYS Therapeutics Inc
$16
Spectrum Pharmaceuticals Inc.
$15
Verastem, Inc.
$15
Innate Pharma, Inc
$15
Blueprint Medicines Corporation
$13
Seattle Genetics, Inc.
$12
Acrotech Biopharma LLC
$12
Emmaus Medical, Inc.
$8
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Alecensa · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CHANTIX · COPIKTRA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · ELIQUIS · ENHERTU · ENJAYMO · ERLEADA · Empaveli · Endari · Erleada · FARYDAK · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · Lenvima · Lonsurf · Lumoxiti · MEKINIST · MONJUVI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · OGSIVEO · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · PADCEV · PIQRAY · PROMACTA · PROVENGE · Padcev · Pedmark · Polivy · Pomalyst · Prolia · REBLOZYL · RYDAPT · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sylvant · TASIGNA · TECENTRIQ · THERASPHERE-BIO · TIBSOVO · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VOTRIENT · Vectibix · Venclexta · XALKORI · XARELTO · XOSPATA · XT CDX · XTANDI · Xermelo · Xospata · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,638
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rakkhit is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rakkhit experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Rakkhit performed 77,520 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rakkhit receive payments from pharmaceutical companies?
Yes. Dr. Rakkhit received a total of $13,481 from 75 companies across 586 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rakkhit's costs compare to other internal medicine physicians in Houston?
Dr. Rakkhit's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rakkhit) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Houston
Browse internal medicine physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
SERVIER PHARMACEUTICALS LLC Payments to Doctors
See all physicians who received payments from SERVIER PHARMACEUTICALS LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology